At Lacerta Bio, we believe that business development is a process...a process with discrete steps, activities, timeframes, and deliverables. Yet many companies, fully aware of how to run…
How much does it cost to develop an approved drug? We may never know, but Matt Herper from Forbes takes an interesting approach to come up with some estimates.
Texas-based Pernix Therapeutics announced a $30 million divestment of a portfolio of generic assets to Breckenridge: Under the terms of the agreement, Breckenridge will pay…
We don't normally comment on stock activity, but the market response to the Perrigo Elan announcement caught our eye: As was pointed out in The Guardian: Perrigo, which…
According to Burrill & Company, July had the busiest week of biotech IPO activity ever, continuing a trend of heavy fundraising during 2013 so far: In all, 29…
In a surprise decision last week, the US FDA decided to approve Brisdelle, a low-dose formulation of paroxetine, for the treatment of menopausal hot flashes. This comes on…
Many people think of the BRIC countries as good domestic opportunities. But as this recent article points out, the Indian export market is growing rapidly. India's leading pharmaceutical…
Ok, we have to admit. This is not exactly a "how to" guide. In fact, writing such a guide may not be possible. But first, let's dispel the…
Just sign a piece a paper and drive off with a new car. They sure make it sound east, don't they? Yet VW does have a good point.…
Biotech business development has become more sophisticated and more complex. Yet we see companies running processes which are suboptimal. Here is a case in point. We're reviewing several…